Liraglutide for Children 6 to <12 Years of Age with Obesity - A Randomized Trial.
Claudia K FoxMargarita Barrientos-PérezEric M BombergJohn DcruzInge GiesNina M Harder-LauridsenMuhammad Yazid JalaludinKushal SahuPetra WeimersThomas ZuegerSilva A Arslaniannull nullPublished in: The New England journal of medicine (2024)
Among children (6 to <12 years of age) with obesity, treatment with liraglutide for 56 weeks plus lifestyle interventions resulted in a greater reduction in BMI than placebo plus lifestyle interventions. (Funded by Novo Nordisk; SCALE Kids ClinicalTrials.gov number, NCT04775082.).